1. Sixty-Third World Health Assembly WHO: Human organ and tissue transplantation. Resolution WHA 63.22 of the Sixty-Third World Health Assembly. Cell Tissue Bank 2010, 11(4):411-412.
2. [http://www.who.int/news-room/fact-sheets/detail/congenital-anomalies]
3. [https://www.who.int/en/news-room/fact-sheets/detail/children-reducing-mortality]
4. Health CMo: China Birth Defect Prevention Report (2012). In.; 2012.
5. Xuelei Yin XD, Mingzhu Yao: Analysis on the composition of 481 neonates with congenital malformation and their associated factors. j Clin Pediatr 2008, 26(3):204-208.
6. Proceedings of the Joint Nutrition Symposium of the European Society of Veterinary and Comperative Nutrition, the European College of Veterinary and Comperative Nutrition, the American Academy of Veterinary Nutrition, the American College of Veterinary Nutrition, the European Zoo Nutrition Research Group, and the Comperative Nutrition Society. August 21-25, 2002. Antwerp, Belgium. J Anim Physiol Anim Nutr (Berl) 2004, 88(3-4):73-177.
7. Organization WH: Serum and red blood cell folate concentrations for assessing folate status in populations, vol. Vol. WHO/NMH/NHD/EPG/15.01; 2015.
8. Czeizel AE, Dudas I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327(26):1832-1835.
9. Wang H, De Steur H, Chen G, Zhang X, Pei L, Gellynck X, Zheng X: Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region. Nutrients 2016, 8(3):152.
10. Williams J, Mai CT, Mulinare J, Isenburg J, Flood TJ, Ethen M, Frohnert B, Kirby RS, Centers for Disease C, Prevention: Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep 2015, 64(1):1-5.
11. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP: Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010(10):CD007950.
12. Khoshnood B, Loane M, de Walle H, Arriola L, Addor MC, Barisic I, Beres J, Bianchi F, Dias C, Draper E et al: Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ 2015, 351:h5949.
13. Cordero AM, Crider KS, Rogers LM, Cannon MJ, Berry RJ: Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb Mortal Wkly Rep 2015, 64(15):421-423.
14. Czeizel AE, Dudas I, Vereczkey A, Banhidy F: Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients 2013, 5(11):4760-4775.
15. Liu S, Joseph KS, Luo W, Leon JA, Lisonkova S, Van den Hof M, Evans J, Lim K, Little J, Sauve R et al: Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes. Circulation 2016, 134(9):647-655.
16. Wehby GL, Murray JC: Folic acid and orofacial clefts: a review of the evidence. Oral Dis 2010, 16(1):11-19.
17. Li S, Chao A, Li Z, Moore CA, Liu YH, Zhu JH, Erickson JD, Hao L, Berry RJ: Folic Acid Use and Nonsyndromic Orofacial Clefts in China A Prospective Cohort Study. Epidemiology 2012, 23(3):423-432.
18. Czeizel AE: Is folic acid a risk factor for oral clefts? Eur J Epidemiol 2013, 28(11):841-843.
19. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, Denheijer M, Kluijtmans LAJ, Vandenheuvel LP et al: A Candidate Genetic Risk Factor for Vascular-Disease - a Common Mutation in Methylenetetrahydrofolate Reductase. Nat Genet 1995, 10(1):111-113.
20. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ: Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. American Journal of Epidemiology 1998, 148(1):30-37.
21. Mamasoula C, Prentice RR, Pierscionek T, Pangilinan F, Mills JL, Druschel C, Pass K, Russell MW, Hall D, Topf A et al: Association Between C677T Polymorphism of Methylene Tetrahydrofolate Reductase and Congenital Heart Disease: Meta-Analysis of 7697 Cases and 13 125 Controls. Circ-Cardiovasc Gene 2013, 6(4):347-353.
22. Zhao JY, Qiao B, Duan WY, Gong XH, Peng QQ, Jiang SS, Lu CQ, Chen YJ, Shen HB, Huang GY et al: Genetic variants reducing MTR gene expression increase the risk of congenital heart disease in Han Chinese populations. Eur Heart J 2014, 35(11):733-742.
23. Zhao JY, Yang XY, Gong XH, Gu ZY, Duan WY, Wang J, Ye ZZ, Shen HB, Shi KH, Hou J et al: Functional Variant in Methionine Synthase Reductase Intron-1 Significantly Increases the Risk of Congenital Heart Disease in the Han Chinese Population. Circulation 2012, 125(3):482-+.
24. Zhao JY, Yang XY, Shi KH, Sun SN, Hou J, Ye ZZ, Wang J, Duan WY, Qiao B, Chen YJ et al: A functional variant in the cystathionine beta-synthase gene promoter significantly reduces congenital heart disease susceptibility in a Han Chinese population. Cell Res 2013, 23(2):242-253.
25. Wang DA, Wang F, Shi KH, Tao H, Li Y, Zhao R, Lu H, Duan WY, Qiao B, Zhao SM et al: Lower Circulating Folate Induced by a Fidgetin Intronic Variant Is Associated With Reduced Congenital Heart Disease Susceptibility. Circulation 2017, 135(18):1733-+.
26. Rydberg C, Tunon K: Detection of fetal abnormalities by second-trimester ultrasound screening in a non-selected population. Acta Obstet Gyn Scan 2017, 96(2):176-182.
27. Nilsen RM, Leoncini E, Gastaldi P, Allegri V, Agostino R, Faravelli F, Ferrazzoli F, Finale E, Ghirri P, Scarano G et al: Prevalence and determinants of preconception folic acid use: an Italian multicenter survey. Ital J Pediatr 2016, 42(1):65.
28. Wang Dingmei ZY, Ye Ying, Jiang Yuan, Ma Xiao-jing, Yan Wei-li, Huang Guo-ying: A cross-sectional study on prevalence of paternal and parental preconception folic acid supplement use and its influencing factors. Chinese Journal of Evidence-based Pediatrics. 12(1) 2017:1-6.
29. Cueto HT, Riis AH, Hatch EE, Wise LA, Rothman KJ, Mikkelsen EM: Predictors of preconceptional folic acid or multivitamin supplement use: a cross-sectional study of Danish pregnancy planners. Clin Epidemiol 2012, 4:259-265.
30. Hoyo C, Murtha AP, Schildkraut JM, Forman MR, Calingaert B, Demark-Wahnefried W, Kurtzberg J, Jirtle RL, Murphy SK: Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST). BMC Public Health 2011, 11(1):46.
31. Liu Yan CY, Sun Xiao, Wang Jinling, Liu Qilan: Analysis on the dietary survey results of preconceptional couples in Liyang city, Jiangsu province. MATERNAL & CHILD HEALTH CARE OF CHINA 2011, 2011, 26(21).
32. Lixin Zheng ML, Qiling Wang, Shanshan Xu, Ganhua Pan, Jiangchu Huang, Meizhen Zeng: Investigation on birth defects of fetus after twelve weeks pregnancy and chiIdren with 0-5 yares old in part area of Guangdong prevince chin J Fam Plann 2017, 25(2):93-97.
33. Blencowe H, Cousens S, Modell B, Lawn J: Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010, 39 Suppl 1:i110-121.
34. Measures for the implementation of the law of the People's Republic of China on maternal and infant health care [http://www.chinawch.org.cn/zfcg/flfg/200809/t20080917_49941.html]
35. Heil SG, Van der Put NMJ, Waas ET, den Heijer M, Trijbels FJM, Blom HJ: Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 2001, 73(2):164-172.
36. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP: A polymorphism (80G-> A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000, 70(4):310-315.
37. Huang T, Tucker KI, Lee YC, Crott JW, Parnell LD, Shen JA, Smith CE, Ordovas JM, Li D, Lai CQ: Methylenetetrahydrofolate Reductase Variants Associated with Hypertension and Cardiovascular Disease Interact with Dietary Polyunsaturated Fatty Acids to Modulate Plasma Homocysteine in Puerto Rican Adults. Journal of Nutrition 2011, 141(4):654-659.
38. Saraswathy KN, Asghar M, Samtani R, Murry B, Mondal PR, Ghosh PK, Sachdeva MP: Spectrum of MTHFR gene SNPs C677T and A1298C: a study among 23 population groups of India. Mol Biol Rep 2012, 39(4):5025-5031.
39. Field MS, Kamynina E, Agunloye OC, Liebenthal RP, Lamarre SG, Brosnan ME, Brosnan JT, Stover PJ: Nuclear Enrichment of Folate Cofactors and Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) Protect de Novo Thymidylate Biosynthesis during Folate Deficiency. J Biol Chem 2014, 289(43):29642-29650.